Labcorp will close a facility it just acquired as part of a $237.5 million deal and lay off most of the workers there.

LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Health's laboratory testing businesses.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

OAKLAND — Labcorp has opened its first patient service center in Oakland, expanding access to high-quality lab services for ...

Labcorp Holdings LH underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to ...

Analyst Eric Coldwell of Robert W. Baird reiterated a Buy rating on Laboratory (LH – Research Report), retaining the price target of ...

EQS-News: SYNLAB AG / Key word (s): Miscellaneous Cinven to sell minority stake in SYNLAB to strategic investor Labcorp 17.09.2024 / 16:00 CET/CEST The issuer is solely responsible for the content ...

Ballad Health announced today it has reached agreement on a strategic collaboration with Labcorp, a global leader of ...

Enhances Labcorp's laboratory services network and expands access to its clinical services BURLINGTON, N.C. and MIAMI, Sept. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative ...

BURLINGTON, N.C. and MIAMI, Sept. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health ...

Labcorp will operate the system's outreach services while Ballad will continue to operate services including its inpatient and emergency department laboratories.